Mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome is one of many mitochondrially inherited multisystem diseases. The features of 110 reported mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes patients are reviewed to define the clinical spectrum of this disease. The clinical disorder, in addition to emerging concepts of genetic etiology, is promoting our understanding of mitochondrial functions. New knowledge may lead to more rational therapies. Finally, the recent revolution in the study of mitochondrial diseases may further our understanding of other degenerative disorders and even aging. (J Child Neurol 1994;9:04-13).
Engel WK, Cunningham G.:Rapid examination of muscle tissue: An improved trichrome stain method for fresh frozen biopsy section. NeuroLogy1963 ;19:919-923.
3.
Berenberg RA , Pellock JM, DiMauro S.: Lumping or splitting? "Ophthalmoplegia plus" orKearns- Sayre syndrome? Ann Neurol1977;1:37-43.
4.
Rowland LP , Hays AP, DiMauro S., et al: Diverse clinical disorders associated with morphological abnormalities of mitochondria, in Cerri C, Scarlato G (eds): Mitochondrial Pathology in Muscle Disease. Padua, Piccin Editore, 1983, pp 141-158.
5.
Fukuhara N., Tokigushi S., Shirakawa K., Tsubaki T.: Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): Disease entity or syndrome? Light and electron microscopic studies of two cases and review of the literature. J Neurol Sci1980;47:117-133.
6.
Pavlakis SG, Phillips PC, DiMauro S., et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome. Ann Neurol1984; 16:481-488.
7.
Petty RKH , Harding AE, Morgan-Hughes JA: The clinical features of mitochondrial myopathy . Brain1986;109:915-938.
8.
Rowland LP, Blake DM, Hirano M., et al: Clinical syndromes associate with ragged-red fibers. Rev Neurol1991;147:467-473.
9.
Shoffner JM, Lott MT, Lezza A., et al: Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell1990;61:931-937.
10.
Silvestri G. , Moraes CT, Shanske S., et al: A new mtDNA mutation in the tRNALys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet1992;51: 1213-1217.
11.
GotoY-i, Nonaka I, Horai S: A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature1990; 348:651-653.
12.
GotoY-i, Nonaka I, Horai S: A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) . Biochem Biophys Acta1991;1097:238-240.
13.
Lertrit P., Noer A., Jean-François MJB, et al: A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I. Am J Hum Genet1992;51:457-468.
14.
Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of mitochondrial DNA in patients with mitochondrial myopathies . Nature1988;331:717-719.
15.
Zeviani M. , Moraes CT, DiMauro S., et al: Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology1988;38: 1339-1346.
16.
Zeviani M. , Muntoni F., Savarese N., et al: A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNALys gene. Eur J Hum Genet1992;1:80-87.
17.
Benda C.: Weitere Mitteilungen uber die Mitochondria. Verh Physiol Ges Berlin1898:376-383.
18.
Tzagoloff A.: Mitochondria. New York, Plenum, 1982.
19.
Lehninger A. : The Mitochondrion. New York, WABenjamin, 1964.
20.
Schatz G., Haslbrunner E., Tuppy H.: Deoxyribonucleic acid associated with yeast mitochondria. Biochem Biophys Res Commun1964;15:127-135.
21.
Anderson S. , Bankier AT, Barrell BG, et al: Sequence and organization of the human mitochondrial genome. Nature1981; 290:457-465.
22.
Tritschler H., Medori R.: Mitochondrial DNA alterations as source of human disorders. Neurology1993 ;43:280-288.
23.
Luft R., Ikkos D., Palmieri G., et al: A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical, and morphological study. J Clin Invest1962;41: 1776-1804.
24.
Olson W., Engel W., Walsh G., Einaugler R.: Oculocraniosomatic neuromuscular disease with ragged red fibers. Arch Neurology1972;26:193-211.
25.
Zeviani M., Gellera C., Antozzi C., et al: Maternally inherited myopathy and cardiomyopathy: Association with mutation in mitochondrial DNA tRNA. Lancet1991;338:143-147.
26.
Wallace DC, Singh G., Lott MT, et al: Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science1988;242:1427-1430.
27.
Howell N., Kubacka I., Xu M., McCullough DA: Leber hereditary optic neuropathy: Involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet1991;48:935-942.
28.
Brown M., Voljavec A., Lott M., et al: Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics1992;130:163-173.
29.
Brown M., Yang C-C., Trounce I., et al: A mitochondrial DNA variant, identified in Leber hereditary optic neuropathy patients, which extends the amino acid sequence of cytochrome c oxidase subunit I. Am J Hum Genet1992;51:378-385.
30.
Brown M., Voljavec A., Lott M., et al: Leber's hereditary optic a model for mitochondrially inherited disease. FASEB J1992;6:2791-2799.
31.
Johns DR, Neufeld MJ: Cytochrome b mutations in Leber hereditary optic neuropathy. Biochem Biophys Res Commun1991;181:1358-1364.
32.
Mackey D., Howell N.: A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet1992;51: 1218-1228.
33.
Holt I., Harding A., Petty R., Morgan-Hughes J.: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy . Am J Hum Genet1990:46:428-433.
34.
Van Ervan PMM , Gabreëls FJM, Wevers RA, et al: Intravenous pyruvate loading test in Leigh syndrome. J Neurol Sci1987;77:217-227.
35.
DiMauro S., Servidei S., Zeviani M., et al: Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol1987;22:498-506.
36.
Robinson BH , De Meirleir L., Glerum M., et al: Clinical presentation of mitochondrial respiratory chain defects in NADH-coenzyme Q reductase and cytochrome oxidase: Clues to pathogenesis of Leigh disease. J Pediatr1987;110:216-222.
37.
Tatuch Y., Christodoulou J., Feigenbaum A., et al: Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet1992;50:852-858.
38.
Hirano M., DiMauro S.: Clinical features of mitochondrial myopathies and encephalomyopathies , in Lane R (ed): Handbook of Clinical Myology. New York, Marcel Dekker, in press.
39.
Hirano M., Ricci E., Koenigsberger M., et al: MELAS: An original case and clinical criteria for diagnosis . Neuromusc Disord1992;2:125-135.
40.
Gardner-Medwin D., Dale G., Parker JM: Lactic acidosis with mitochondrial myopathy and recurrent coma (abstract). Presented at the First International Congress ofChild Neurology, 1975, p 47.
41.
Shapira Y., Cederbaum SC, Cancilla PA, et al: Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Neurology1975;25:614-621.
42.
Hart Z., Chang C-H., Perrin E., et al: Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Arch Neurol1977;34:180-185.
43.
Britton D., Pellock J., Eiben R.: Acute hemiplegia of childhood, lactate-pyruvate acidemia, and mitochondrial disorder. Ann Neurol1977;2:265.
44.
Askanas V., Engel WK, Britton D., et al: Reincarnation in cultured muscle of mitochondrial abnormalities . Arch Neurol1978;35:801-809.
45.
Skoglund R. : Reversible alexia, mitochondrial myopathy, and lactic acidemia. Neurology1979;29:717-720.
46.
Kobayashi Y. , Miyabayashi S., Takada G., et al: Ultrastructural study of the childhood mitochondrial myopathic syndrome associated with lactic acidosis. Eur J Pediatr1982;139:25-30.
47.
Bogousslavsky J., Perentes E., Deruaz J., Regli F.: Mitochondrial myopathy and cardiomyopathy with neurodegenerative features and multiple brain infarcts. J Neurol Sci1982;55:351-357.
48.
Yamamoto T. , Beppu H., Tsubaki T.: Mitochondrial encephalomyopathy: Fluctuating symptoms and CT. Neurology1984 ;34: 1456-1460.
49.
Kuriyama M. , Umezaki H., Fukuda Y., et al: Mitochondrial encephalomyopathy with lactate-pyruvate elevations and brain infarctions. Neurology1984;34:72-77.
50.
Hayes D., Hilton-Jones D., Arnold D., et al: A mitochondrial encephalomyopathy: A combined 31P magnetic resonance and biochemical investigation. J Neurol Sci1985;71:105-118.
51.
Mukoyama M. , Kazui H., Sunohara N., et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: A clinicopathological study of a unique case. J Neurol1986;233:228-232.
52.
Peterson P. , Martens M., Lee C-P., et al: MELAS: A disorder of mitochondrial metabolism. Neurology1986 ;36(Suppl 1):94.
53.
Rating D., Hanefeld F., Sperner J., et al: MELAS: Clinical, biochemical, and neuropathological findings in a further case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (abstract). Presented at the 24th Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Amersfoort, The Netherlands, September 1986.
54.
Kobayashi M. , Morishita H., Sugiyama N., et al: Two cases of NADH-coenzyme Q reductase deficiency: Relationship to MELAS syndrome. J Pediatr1987;110:223-227.
55.
Driscoll P. , Larsen P., Gruber A.: MELAS syndrome involving a mother and two children. Arch Neurol1987 ;44:971-973.
56.
Goda S., Ishimoto S., Goto I., et al: Biochemical studies in mitochondrial encephalomyopathy. J Neurol Neurosurg Psychiatry1987;50:1348-1352.
57.
Hasuo K., Tamura S., Yasumori K., et al: Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes): Report of 3 cases. Neuroradiology1987;29:393-397.
58.
Ishitsu T. , Miike T., Kitano A., et al: Heterogeneous phenotypes of mitochondrial encephalomyopathy in a single kindred. Neurology1987;37:1867-1869.
59.
Nishizawa M. , Tanaka K., Shinozawa K., et al: A mitochondrial encephalomyopathy with cardiomyopathy. J Neurol Sci1987;78:189-201.
60.
Ohama E., Ohara S., Ikuta F., et al: Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (Berl) 1987;74:226-233.
61.
Oldfors A., Tulinius M., Holme E., et al: Mitochondrial encephalomyopathy. A variant with heart failure and liver steatosis. Acta Neuropathol (Berl) 1987;74:287-293.
62.
Yamamoto M. , Sato T., Anno M., et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration. J Neurol Neurosurg Psychiatry1987;50:1475-1481.
63.
Yamanaka R. , Nomura Y., Segawa M., Nonaka I.: MELAS, myoclonus, ataxia and deficiencies of complexes I and IV in muscle mitochondria. Acta Paediatr Jpn1987;29:761-767.
64.
Allard J., Tilak S., Carter A.: CT and MR of MELAS syndrome. AJNR1988;9:1234-1238.
65.
Brendingstall G., Lockman L.: Massive focal brain swelling as a feature of MELAS. Pediatr Neurol1988;4:366-370.
66.
Danks R., Dorevitch M., Cummins J., Byrne E.: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): Adolescent onset with severe cerebral edema. Aust N Z J Med1988;18:69-72.
67.
Ichiki T., Tanaka M., Nishikimi M., et al: Deficiency of subunits of complex I and mitochondrial encephalomyopathy . Ann Neurol1988;23:287-294.
68.
Kishi M., Yamamura Y., Kurihara T., et al: An autopsy case of mitochondrial encephalomyopathy: Biochemical and electron microscopic studies of the brain. J Neurol Sci1988;86:31-40.
69.
Koga Y., Nonaka I., Kobayashi M., et al: Findings in muscle in complex I (NADH coenzyme Q reductase) deficiency. Ann Neurol1988;24:749-756.
70.
Kotagal S., Peterson P., Martens M., et al: Impaired NADH-CoQ reductase activity in a child with moyamoya syndrome. Pediatr Neurol1988;4:241-244.
71.
Montagna P. , Gallassi R., Medori R., et al: MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission . Neurology1988;38:751-754.
72.
Destée A., Martin J., Müller J., et al: Myopathie mitochondriale. Encéphalopathie avec acidose lactique et infarctus cérébraux. Rev Neurol (Paris) 1989;145:37-48.
73.
Hamazaki S. , Okada S., Kusaka H., et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Report of an autopsy. Acta Pathol Japonica1989;39:599-606.
74.
Ihara Y., Namba R., Kuroda S., et al: Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone. J Neurol Sci1989;90: 263-271.
75.
Morita K., Ono S., Fukunaga M., et al: Increased accumulation of N-isopropyl-p-(123I)-iodoamphetamine in two cases with mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS). Neuroradiology1989;31:358-361.
76.
Seyama K., Suzuki K., Mizuno Y., et al: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with special reference to the mechanism of cerebral manifestations . Acta Neurol Scand1989;80:561-568.
77.
Abe K., Inui T., Hirono N., et al: Fluctuating MR images with mitochondrial encephalopathy, lactic acidosis, stroke-like syndrome (MELAS). Neuroradiology1990;32:77.
78.
Rosen L., Phillips S., Enzmann D.: Magnetic resonance imaging in MELAS syndrome. Neuroradiology1990;32:168-171.
79.
Schapira A. , Cooper J., Manneschi L., et al: A mitochondrial encephalomyopathy with specific deficiencies of two respiratory chain polypeptides and a circulating autoantibody to a mitochondrial matrix protein. Brain1990;113:419-432.
80.
Suzuki T., Koizumi J., Shiraishi H., et al: Mitochondrial encephalomyopathy (MELAS) with mental disorder CT, MRI and SPECT findings. Neuroradiology1990;32:74-76.
81.
van Hellenberg-Hubar J., Gabreëls F., Ruitenbeek W., et al: MELAS syndrome. Report of two patients, and comparison with data of 24 patients from the literature . Neuropediatrics1991 ;22:10-14.
82.
Morgan-Hughes JA, Hayes DJ, Clark JB, et al: Mitochondrial encephalomyopathies: Biochemical studies in two cases revealing defects in the respiratory chain . Brain1982;105:553-582.
83.
Horiguchi Y. , Fujii T., Imamura S.: Purpuric cutaneous manifestations in mitochondrial encephalomyopathy. J Dermatol1991; 18:295-301.
84.
Matthews P. , Tampieri D., Berkovic S., et al: Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology1991;41:1043-1046.
85.
Obermaier-Kusser B., Paetzke-Brunner I., Enter C., et al: Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNALeu(UUR)]. FEBS Lett1991;286:67-70.
86.
Forster C., Hubner G., Müller-Hocker J., et al: Mitochondrial angiopathy in a family with MELAS. Neuropediatrics1992;23: 165-168
87.
Inui K., Fukushima H., Tsukamoto H., et al: Mitochondrial encephalomyopathies with the mutation of the mitochondrial tRNALeu(UUR) gene. J Pediatr1992;120:62-66.
88.
Lertrit P., Noer A., Jean-François MJB, et al: A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND1 subunit of the respiratory complex I. Am J Hum Genet1992;51:457-468.
89.
Ciafaloni E. , Ricci E., Shanske S., et al: MELAS: Clinical features, biochemistry, and molecular genetics. Ann Neurol1992;31: 391-398.
90.
Martinuzzi A., Bartolomei L., Carrozzo R., et al: Correlation between clinical and molecular features in two MELAS families. J Neurol Sci1991;113:222-229.
91.
Grunwald F. , Zierz S., Broich K., et al: HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). J Nucl Med1990;31:1740-1742.
92.
Satoh M., Ishikawa N., Yoshizawa T., et al: N-Isopropyl-p-[123I]iodoamphetamine SPECT in MELAS syndrome: Comparison with CT and MR imaging. J Comput Assist Tomogr1991; 15:77-82.
93.
Mosewich R. , Donat J., DiMauro S., et al: The syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes presenting without stroke. Arch Neurol1993 ;50: 275-278.
94.
Watahiki Y. , Tomiyama M., Nagata K., et al: Positron emission tomographic study in patients with MELAS. Brain Nerve1988; 20:404-411.
95.
Sakuta R., Nonaka I.: Vascular involvement in mitochondrial myopathy. Ann Neurol1989;25:594-601.
96.
Moraes CT, Ricci E., Bonilla E., et al: The mitochondrial tRNALeu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): Genetic, biochemical, and morphological correlations in skeletal muscles. Am J Hum Genet1992;50:934-939.
97.
Hasegawa H. , Matusoka T, GotoY-i, Nonaka I: Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Ann Neurol1991;29:610-615.
98.
Moraes CT, Ciacci F., Silvestri G., et al: Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord , 1993; 3:43-50.
99.
van den Ouweland J., Lemkes H., Ruitenbeek W., et al: Mutation in mitochondrial tRNA Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet1992;1:368-371.
100.
King MP, Koga Y., Davidson M., Schon EA: Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol1992; 12:480-490.
101.
Lenaz G., De Santis A., Bertoli E.: A survey of the function and specificity of ubiquinone in the mitochondrial respiratory chain, in Lenaz G (ed): Coenzyme Q. New York, Wiley, 1985, pp 165-199.
102.
Lenaz G., Espoti M.: Physical properties of ubiquinones in model systems and membranes , in Lenaz G (ed): Coenzyme Q . New York, Wiley, 1985, pp 83-105.
103.
DeVivo DC, Jackson A., Wade C., et al: Dichloroacetate treatment of MELAS-associated lactic acidosis. Ann Neurol1990;28: 437.
104.
Saito T., Naito E., Ito M., et al: Therapeutic effects of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics1991;22:166-167.
105.
Shoffner JM , Wallace DC: Oxidative phosphorylation diseases. Disorders of two genomes. Adv Hum Genet1990 ;19:267-330.
106.
Penn AMW , Lee JWK , Thuillier P., et al: MELAS syndrome with mitochondrial tRNA mutation: Correlation of clinical state, nerve conduction, and muscle P31 magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology1992;42:2147-2152.
107.
Pavlakis SG , Gould R., Zito J.: Stroke in children . Adv Pediatr1990;38:151-179.
108.
Choi D.: Bench to bedside: The glutamate connection. Science1992;258:241-243.
109.
Boulet L., Karpati G., Shoubridge E.: Distribution and threshold expression of the tRNA mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet1992;51:1187-1200.
110.
Chomyn A., Meola N., Bresolin N., et al: In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria . Mol Cell Biol1991;11:2236-2244.
111.
Larsson N-G. , Holme E., Kristiansson B., et al: Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome . Pediatr Res1990;28:131-136.
112.
Johnson MA , Bindoff LA, Turnbull DM: Cytochrome c oxidase activity in single muscle fibers: Assay techniques and diagnostic applications . Ann Neurol1993;33:28-35.
113.
Kobayashi Y., Momoi M., Tominaga K., et al: Respiratory-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) . Am J Hum Genet1991;49:590-599.
114.
King MP, Attardi G.: Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation . Science1989;246:500-503.
115.
Christianson T., Clayton D.: In vitro transcription of human mitochondrial DNA: Accurate termination requires a region of DNA sequence that can function bidirectionally. Proc Natl Acad Sci USA1986 ;83:6277-6281.
116.
Gelfand R. , Attardi G.: Synthesis and turnover of mitochondrial ribonucleic acid in HeLa cells: The mature ribosomal and messenger ribonucleic acid species are metabolically unstable. Mol Cell Biol1981;1:497-511.
117.
Hess J., Parisi M., Bennett J., Clayton D.: Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature1991;351:236-239.
118.
Schon EA, Koga Y., Davidson M., et al: The mitochondrial tRNALeu(UUR) mutation in MELAS: A model for pathogenesis. Biochim Biophys Acta1992;1101:206-209.
119.
Trounce I. , Byrne E., Marzuki S.: Decline in skeletal muscle mitochondrial function: Possible factors in aging. Lancet1989;1:637-639.
120.
Linnane A. , Baumer A., Maxwell R., et al: Mitochondrial gene mutation: The aging process and degenerative diseases. Biochem Int1990;22:1067-1076.
121.
Wallace DC : Mitochondrial genetics: A paradigm for aging and degenerative diseases?Science1992;33:28-35.
122.
Simonetta S., Chen X., DiMauro S., Schon EA: Accumulation of deletions in human mitochondrial DNA during normal aging by quantitative PCR . Biochim Biophys Acta1992;1180:113-122.
123.
Parker W., Boyson S., Parks J.: Evidence for a defect in NADH: Ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology1990 ;40:1231-1234.
124.
Parker W., Filley C., Parks J.: Cytochrome oxidase deficiency in Alzheimer's disease. Neurology1990;40:1302-1307.
125.
Parker W., Boyson S., Parks J.: Abnormalities of the electron transport chain in idiopathic Parkinson's disease . Ann Neurol1989;26:719-723.
126.
Shoffner J. , Watts R., Juncos J.: Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol1991;30:332-339.
